A detailed history of Westover Capital Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Westover Capital Advisors, LLC holds 5,028 shares of NVO stock, worth $528,241. This represents 0.12% of its overall portfolio holdings.

Number of Shares
5,028
Previous 5,028 -0.0%
Holding current value
$528,241
Previous $717,000 16.6%
% of portfolio
0.12%
Previous 0.19%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

BUY
$87.78 - $105.45 $57,934 - $69,597
660 Added 15.11%
5,028 $520,000
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $198,612 - $435,795
2,184 Added 100.0%
4,368 $397,000
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $208,091 - $255,375
2,184 New
2,184 $218,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Westover Capital Advisors, LLC Portfolio

Follow Westover Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westover Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Westover Capital Advisors, LLC with notifications on news.